The role of T cells in infection-driven interstitial pneumonia after bone marrow transplantation in mice

Transplantation

Volumn 62, Issue 4, 1996, Pages 517-525

  Garvy, Beth A ^a   Harmsen, Allen G ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; FEMALE; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTERSTITIAL PNEUMONIA; MOUSE; NONHUMAN; PATHOGENESIS; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE; WHOLE BODY RADIATION;

EID: 0029819136     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199608270-00015     Document Type: Article

References (35)

1. Wingard JR, Mellits ED, Sostrin MB, et al. Interstitial pneumonitis after allogeneic bone marrow transplantation. Medicine 1988; 67: 175.
2. Meyers JD, Flournoy N, Thomas ED. Nonbacterial pneumonia after allogeneic marrow transplantation: a review often years experience. Rev Infect Dis 1982; 4: 1119.
3. Krowka MJ, Rosenow EC, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest 1985; 87: 237.
4. Hackman RC. Lower respiratory tract. In: Sale GE, Shulman HM, eds. The pathology of bone marrow transplantation. New York: Masson, 1984: 156.
5. Appelbaum FR, Sullivan KM, Buckner CD, et al. Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. J Clin Oncol 1987; 5: 1340.
6. Beschorner WE, Saral R, Hutchin GM, Tutschka PJ, Santos GW. Lymphocytic bronchitis associated wtih graft-versus-host disease in recipients of bone marrow transplants. N Engl J Med 1978; 299: 1030.
7. Winston DJ, Gale RP, Meyer DV, Young LS. Infectious complications of human bone marrow transplantation. Medicine 1978; 58: 1.
8. Grundy JE, Shanley JD, Shearer GM. Augmentation of graft-versus-host reaction by cytomegalovirus infection resulting in interstitial pneumonitis. Transplantation 1985; 39: 548.
9. Down J, Mauch P, Warhol M, Neben S, Ferrara JLM. The effect of donor T lymphocytes and total-body irradiation on hemopoietic engraftment and pulmonary toxicity following experimental allogeneic bone marrow transplantation. Transplantation 1992; 54: 802.
10. Chen W, Gigliotti F, Harmsen AG. Latency is not an inevitable outcome of infection with Pneumocystis carinii. Infect Immunol 1993; 61: 5406.
11. Hamilton BL, Parkman R. Acute and chronic graft-versus-host disease induced by minor histocompatibility antigens in mice. Transplantation 1983; 36: 150.
12. Garvy BA, Elia JM, Hamilton BL, Riley RL. Suppression of B cell development as a result of selective expansion of donor T cells during the minor H antigen graft-versus-host reaction. Blood 1993; 82: 2758.
13. Jones M, Riley R, Hamilton BL, Paupe J, Perez D, Levy RB. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma. Bone Marrow Transplant 1994; 14: 725.
14. Harmsen AG, Stankiewicz M. Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med 1990; 172: 937.
15. Harmsen AG. Role of alveolar macrophages in lipopolysaccaride-induced neutrophil accumulation. Infect Immunol 1988; 56: 1858.
16. Chen W, Mills JW, Harmsen AG. Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of host inflammatory responses. Int J Exp Pathol 1992; 73: 709.
17. Hamilton BL. L3T4-positive T cells participate in the induction of graft-vs-host disease in response to minor histocompatibility antigens. J Immunol 1987; 139: 2511.
18. Leskinen R, Taskinen E, Volin L, Tukiainen P, Ruutu T, Hayry P. Use of bronchoalveolar lavage cytology and determination of protein contents in pulmonary complications of bone marrow transplant recipients. Bone Marrow Transplant 1990; 5: 241.
19. Korngold R, Sprent J. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. J Exp Med 1978; 148: 1687.
20. Subcommittee on Pulmonary Toxicology, National Research Council. Biological Markers in Pulmonary Toxicology. Washington DC: National Academy, 1989: 106.
21. Shanley JD, Pesanti EL, Nugent KM. The pathogenesis of pneumonitis due to murine cytomegalovirus. J Infect Dis 1982; 146: 388.
22. Brody AR, Craighead JE. Pathogenesis of pulmonary cytomegalovirus infection in immunosuppressed mice. J Infect Dis 1974; 129: 677.
23. Korsmeyer SJ, Elfenbein GJ, Goldman CK, Marshall SL, Santos GW, Waldmann TA. B cell, helper T cell, and suppressor T cell abnormalities contribute to disordered immunoglobulin synthesis in patients following bone marrow transplantation. Transplantation 1982; 33: 184.
24. Gale RP, Opelz G, Mickey MR, Graze PR, Saxon A. Immunodeficiency following allogeneic bone marrow transplantation. Transplant Proc 1978; 10: 223.
25. Lum LG, Seigneuret MC, Orcutt-Thordarson N, Noges JE, Storb R. The regulation of immunoglobulin synthesis after HLA-identical bone marrow transplantation: VI. Differential rates of maturation of distinct functional groups within lymphoid subpopulations in patients after human marrow grafting. Blood 1985; 65: 1422.
26. Schwarer AP, Hughes JMB, Trotman-Dickenson B, Krausz T, Goldman JM. A chronic pulmonary syndrome associated wtih graft-versus-host disease after allogeneic marrow transplantation. Transplantation 1992; 54: 1002.
27. Clark JG, Hansen JA, Hertz MI, Parkman R, Jensen L, Peavy HH. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 1993; 147: 1601.
28. Weiner RS, Bortin MM, Gale RP, et al. Interstitial pneumonitis after bone marrow transplantation. Ann Internal Med 1986; 104: 168.
29. Crawford SW, Hackman RC. Clinical course of idiopathic pneumonia after bone marrow transplantation. Am Rev Respir Dis 1993; 147: 1393.
30. Crawford SW, Longton G, Storb R. Acute graft-versus-host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 1993; 12: 225.
31. Sprent J, Schaefer M, Gao E-K, Korngold R. Role of T cell subsets in lethal graft-versus host disease (GVHD) directed to class I versus class II H2 differences. J Exp Med 1988; 167: 556.
32. + T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice. J Exp Med 1987; 165: 1552.
33. Parkman R. Graft-versus-host disease. Annu Rev Med 1991; 42:189.
34. Holda JH, Maier R, Claman HN. Natural suppressor activity in graft-vs-host spleen and normal bone marrow is augmented by IL 2 and interferon-gamma. J Immunol 1986; 137: 3538.
35. Klimpel GR, Annable CR, Cleveland MG, Jerrells RR, Patterson JC. Immunosuppression and lymphoid hypoplasia associated with chronic graft versus host disease is dependent upon IFN-gamma production. J Immunol 1990; 144: 84.